Get news and resources on how COVID-19 may impact the field of transplantation and may transform our understanding of both genotyping and antibody detection.
SureTyper Blood v1.2 is now available to analyze LinkSēq™ RBC, ABO and HPA kits. See new features
These software updates offer new functionality, feature enhancements, and correct known minor issues.
SureTyper 6.1 contains an enhanced Tray Viewer and Well Viewer interface that allows users to visualize the reactivity of our new multi-targeted assays! Whether one target is positive, both targets are positive, or the assay is negative, the updated Tray Viewer and Well Viewer in SureTyper 6.1 provides the user with visibility to the reactivity of this enhanced assay design.
With faster sample-to-sequencing time, less hands-on work, and a streamlined library preparation protocol...
LABScreen™ Single Antigen ExPlex offers the most expansive HLA Antibody test in a Single Well.
Thermo Fisher Scientific Inc. and QIAGEN N.V. today announced that their boards of directors, as well as the managing board of QIAGEN N.V., have unanimously approved Thermo Fisher's proposal to acquire QIAGEN in cash.
Thermo Fisher Scientific Completes CE-IVD Registration of its QuantStudio™ 5 Dx System for In Vitro Diagnostic Use in Europe
SAN DIEGO, July 31, 2017 (PRNewswire) -- AACC -- Thermo Fisher Scientific today announced the successful CE-IVD registration of its QuantStudio 5 Dx Real-Time PCR System for sale in European countries.
CANOGA PARK, Calif. April 7, 2015 (BUSINESS WIRE) --One Lambda, Inc., part of Thermo Fisher Scientific and leading producer of in vitro diagnostic products for the HLA transplant community, today announced the availability of the only FDA cleared and CE marked assay for detecting HNA-3, as well as HLA...
One Lambda, Inc. and GenoDive Pharma, Inc. Enter Exclusivity Agreement on Long-Range Primers for NGS
CANOGA PARK, Calif.--(BUSINESS WIRE)--One Lambda, Inc., part of Thermo Fisher Scientific, announced it has entered into an agreement with Japan-based GenoDive Pharma, Inc. for exclusive rights to their long-range primers and amplification conditions for human leukocyte antigen (HLA) locus-specific amplification. The agreement covers GenoDive’s primers and conditions for HLA A, B, C, DRB1, DRB345, DQA1, DQB1, DPA1 & DPB1 loci.
SAN CARLOS, Calif., Feb. 1, 2019 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a leader in non-invasive genetic testing and the analysis of cell-free DNA, today announced a partnership with Thermo Fisher Scientific's One Lambda brand...
Thermo Fisher Scientific's One Lambda Brand Signs Exclusive Licensing Agreement with Transcriptome Sciences Inc. for access to Molecular Microscope Diagnostic System
CANOGA PARK, Calif., May 16, 2017 (PRNewswire) -- One Lambda, a Thermo Fisher Scientific brand, announced today that it has signed an exclusive licensing agreement with Transcriptome Sciences Inc. (TSI) of Edmonton, Canada for its new microarray biopsy service, the Molecular Microscope™ Diagnostic System (MMDx).
One Lambda Announces the Availability of its New RUO NXType Kit, a Complete Solution for HLA Typing by NGS
CANOGA PARK, Calif.--(BUSINESS WIRE)--One Lambda, Inc., part of Thermo Fisher Scientific and leading producer of research and in vitro diagnostic products for the HLA transplant community, today launched its RUO NXType™ Kit, a research use only (RUO) solution for human leukocyte antigen (HLA) typing by next-generation sequencing (NGS). Last Updated: 2016.05.24 for trademark usage.
Thermo Fisher Scientific’s global team partnered with One Legacy to support the annual Donate Life Run/Walk.
Through the creation of transplant patient education programs, Dr. Waterman's team is determined to end the organ shortage crisis.
Light In The Darkness: One Lambda and OneLegacy Partner To Save & Heal Lives Through Transplantation
This past December, ten volunteers joined hundreds of donor family members, transplant recipients, and transplant professionals in the effort to decorate the Donate Life Rose Parade float.
As a heart and kidney recipient, Regina Armstrong demonstrates both the life-saving power of transplantation and the need for further patient care innovations.
IWD is important not only for women on our team but also for the many women in STEM who face challenges in their career paths, for women advocates who serve the patient community, and for female transplant patients in need of better care.
The One Lambda team assembled care packages for dialysis patients with handwritten notes of encouragement for each patient.
Our very own Louise Lerminaux and friend Conna Jones chatted with #ScienceWithATwist about their journey as a donor & recipient pair and how organ donation has changed both their lives.
Mona Castro shared her family’s poignant story of both giving and receiving the gift of life. Mona's daughter, Sara, is a two-time transplant recipient who was born with severe congenital heart disease.